The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...

A report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The best high-yield dividend stocks we recommend are The Brookfield Renewable Partners L.P., Pfizer, and Healthpeak ...

This week's dividend activity included increased payouts from MetLife (NYSE:MET) and Phillips 66 (PSX) as well as ...

Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...

Pfizer's PFE non-COVID operational revenues improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and ...

Pfizer Inc. (NYSE: PFE) today held its Annual Meeting of Shareholders. Preliminary results from the Annual Meeting indicate that the company's 13 ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the ...

Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...